Cite
MLA Citation
T. E. Coyle et al.. “Phase I study of BAY 94‐9027, a PEGylated B‐domain‐deleted recombinant factor VIII with an extended half‐life, in subjects with hemophilia A.” Journal of thrombosis and haemostasis, vol. 12, n.d., pp. 488–496. http://access.bl.uk/ark:/81055/vdc_100024816248.0x000058